NEU 3.15% $21.27 neuren pharmaceuticals limited

Ann: International institution acquires 14% of Neuren, page-50

  1. 709 Posts.
    lightbulb Created with Sketch. 649
    Think some need to calm the farm here - keep composed and evaluate the unique nature of what Neuren have.


    NEU has a strong balance sheet: at times like this, that is king. We have enough cash to last 2-3 years from quarter end, if required;

    We are late stage with clear path to becoming profitable without the need to raise again, or partner in uncertain environment; and

    Our partner ACADIA has around A$1 b in the bank.


    Future CF and f/cast revenue is unchanged: We have unchanged demand - Covid19 doesn't cure Retts and/or FXS.

    Companies with the attributes above will rebound fast and hardest when financials markets recover and they will.

    At ~-70% from the recent 2020 high are we at the bottom ? Well that probably depends on the liquidity requirements of the register vs demand; but at around $85m EV we are in the zone to accumulate for sure.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.27
Change
0.650(3.15%)
Mkt cap ! $2.718B
Open High Low Value Volume
$20.84 $21.56 $20.76 $7.760M 364.5K

Buyers (Bids)

No. Vol. Price($)
2 1378 $21.24
 

Sellers (Offers)

Price($) Vol. No.
$21.29 218 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.